*Note: This short is expensive and will open up negative if you have to get filled higher than the market.
This is a 1 of 2 short position open.
This stock recently beat a Phase II study. Causing it to gap up AH. Currently up 70% in the last 24 hours. There is a Phase 3 coming up which can cause another 30% to 50%+ run. So, yes this is a high-risk trade.
I expect this company to hit $170 by the end of the day.
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.